Resources from the same session
New and Emerging Targeted Therapies in Non-EGFR/HER2-Mutant NSCLC
Presenter: J. Remon, FR
Session: Session 5 – Hitting Even More Targets in 2024
Resources:
Slides
Webcast
ctDNA in the Management on NSCLC Patients
Presenter: K. M. Kerr
Session: Session 5 – Hitting Even More Targets in 2024
Resources:
Slides
Webcast
Participants Clinical Case Discussion: Clinical Course and Treatment Challenges in HER2-Mutated Non-Small Cell Lung Cancer
Presenter: Ines Margarido, PT
Session: Session 5 – Hitting Even More Targets in 2024
Resources:
Slides
Webcast